menu
    • menu

    Company profile for Sino Biopharmaceutical

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sino Biopharmaceutical Limited and its subsidiaries are the leading innovative research and R&D-driven pharmaceutical group in China, with a business scope that covers the full industry chain of pharmaceutical R&D platforms, intelligent production, and strong sales systems. Its product offerings include a variety of biological drugs and chemical drugs, and it occupies an advantageous position in many potential therapeutic fiel...
    Sino Biopharmaceutical Limited and its subsidiaries are the leading innovative research and R&D-driven pharmaceutical group in China, with a business scope that covers the full industry chain of pharmaceutical R&D platforms, intelligent production, and strong sales systems. Its product offerings include a variety of biological drugs and chemical drugs, and it occupies an advantageous position in many potential therapeutic fields such as liver disease, tumors, cardiovascular and cerebrovascular diseases, orthopedics, digestive system, immune and respiratory diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sino BiopharmaceuticalHongKong Flag
    Country
    Country
    Hong Kong
    Address
    Address
    Unit 09, 41/F, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai
    Telephone
    Telephone
    (+852) 2802 9886
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sinobiopharm.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sino-biopharmaceutical-limited/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Phrontline Pharma Raises $60M for Bispecific, Dual ADCs
    Phrontline Pharma Raises $60M for Bispecific, Dual ADCs

    24 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phrontline-biopharma-raises-60-million-in-pre-a-financing-to-advance-global-development-of-bispecific-and-dual-payload-adcs-302625090.html

    PR NEWSWIRE
    24 Nov 2025
    Share Share
    Sino Biopharma to Acquire Lanova Medicines for Up to $951 M
    Sino Biopharma to Acquire Lanova Medicines for Up to $951 M

    16 Jul 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/sino-biopharmaceutical-acquire-lanova-medicines-up-951-million-2025-07-15/

    REUTERS
    16 Jul 2025
    Share Share
    Inventiva Receives $10 Million Milestone Payment from CTTQ
    Inventiva Receives $10 Million Milestone Payment from CTTQ

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3111282/0/en/Inventiva-receives-10-million-milestone-payment-from-CTTQ.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share
    Global First-in-Class AT2R Antagonist TRD205 Phase II Trial
    Global First-in-Class AT2R Antagonist TRD205 Phase II Trial

    05 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/global-first-in-class-at2r-antagonist-trd205-advances-to-phase-ii-first-patient-dosed-in-chronic-post-surgical-neuropathic-pain-trial-302445546.html

    PR NEWSWIRE
    05 May 2025
    Share Share
    Akeso’s Anniko enters crowded US PD-1 market
    Akeso’s Anniko enters crowded US PD-1 market

    25 Apr 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/akeso-sino-biopharms-anniko-enters-crowded-pd-1-market-fda-approval-head-and-neck-cancer

    FIERCE PHARMA
    25 Apr 2025
    Share Share
    CU Medicine, CTTQ Collaborate On Pharma Innovations In Hong Kong
    CU Medicine, CTTQ Collaborate On Pharma Innovations In Hong Kong

    10 Dec 2024

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/25/25314/cu-medicine-and-cttq-collaborate-to-strengthen-pharma-innovations-in-hong-kong.html

    BIOSPECTRUM
    10 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search